236 related articles for article (PubMed ID: 12808121)
1. Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma.
Horiuchi A; Imai T; Wang C; Ohira S; Feng Y; Nikaido T; Konishi I
Lab Invest; 2003 Jun; 83(6):861-70. PubMed ID: 12808121
[TBL] [Abstract][Full Text] [Related]
2. A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells.
Wang L; Yang L; Luo Y; Zheng Y
J Biol Chem; 2003 Nov; 278(45):44617-25. PubMed ID: 12939257
[TBL] [Abstract][Full Text] [Related]
3. [Correlation of expression of RhoA (RhoC and their effector ROCK-1 with malignant phenotype of ovarian cancer cells in vitro].
Han ZQ; Zhang AL; Wu MF; Liu YL; Chen G; Li FJ; Gao QL; Liao GN; Lu YP; Wang SX; Ma D
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):385-8. PubMed ID: 15355639
[TBL] [Abstract][Full Text] [Related]
4. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.
Faried A; Faried LS; Usman N; Kato H; Kuwano H
Ann Surg Oncol; 2007 Dec; 14(12):3593-601. PubMed ID: 17896152
[TBL] [Abstract][Full Text] [Related]
5. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
6. RhoA and RhoC -siRNA inhibit the proliferation and invasiveness activity of human gastric carcinoma by Rho/PI3K/Akt pathway.
Sun HW; Tong SL; He J; Wang Q; Zou L; Ma SJ; Tan HY; Luo JF; Wu HX
World J Gastroenterol; 2007 Jul; 13(25):3517-22. PubMed ID: 17659701
[TBL] [Abstract][Full Text] [Related]
7. Silencing of RhoA and RhoC expression by RNA interference suppresses human colorectal carcinoma growth in vivo.
Wang H; Zhao G; Liu X; Sui A; Yang K; Yao R; Wang Z; Shi Q
J Exp Clin Cancer Res; 2010 Sep; 29(1):123. PubMed ID: 20828398
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of adenovirus mediated tandem expression of RhoA and RhoC shRNAs in HCT116 cells.
Liu XP; Wang HB; Yang K; Sui AH; Shi Q; Qu S
J Exp Clin Cancer Res; 2009 Apr; 28(1):52. PubMed ID: 19374769
[TBL] [Abstract][Full Text] [Related]
9. The MLK-related kinase (MRK) is a novel RhoC effector that mediates lysophosphatidic acid (LPA)-stimulated tumor cell invasion.
Korkina O; Dong Z; Marullo A; Warshaw G; Symons M; Ruggieri R
J Biol Chem; 2013 Feb; 288(8):5364-73. PubMed ID: 23319595
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
[TBL] [Abstract][Full Text] [Related]
11. Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer.
Kamai T; Tsujii T; Arai K; Takagi K; Asami H; Ito Y; Oshima H
Clin Cancer Res; 2003 Jul; 9(7):2632-41. PubMed ID: 12855641
[TBL] [Abstract][Full Text] [Related]
12. Specific induction of migration and invasion of pancreatic carcinoma cells by RhoC, which differs from RhoA in its localisation and activity.
Dietrich KA; Schwarz R; Liska M; Grass S; Menke A; Meister M; Kierschke G; Längle C; Genze F; Giehl K
Biol Chem; 2009 Oct; 390(10):1063-77. PubMed ID: 19642867
[TBL] [Abstract][Full Text] [Related]
13. Ovarian clear cell carcinomas: RHO GTPases may contribute to explain their singular biologic behavior.
Canet B; Pons C; Espinosa I; Prat J
Hum Pathol; 2011 Jun; 42(6):833-9. PubMed ID: 21208644
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
[TBL] [Abstract][Full Text] [Related]
15. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF
Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197
[TBL] [Abstract][Full Text] [Related]
16. Expression of RhoA and RhoC in colorectal carcinoma and its relations with clinicopathological parameters.
Wang HB; Liu XP; Liang J; Yang K; Sui AH; Liu YJ
Clin Chem Lab Med; 2009; 47(7):811-7. PubMed ID: 19499974
[TBL] [Abstract][Full Text] [Related]
17. The Role of RhoA, RhoB and RhoC GTPases in Cell Morphology, Proliferation and Migration in Human Cytomegalovirus (HCMV) Infected Glioblastoma Cells.
Tseliou M; Al-Qahtani A; Alarifi S; Alkahtani SH; Stournaras C; Sourvinos G
Cell Physiol Biochem; 2016; 38(1):94-109. PubMed ID: 26741994
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas.
Suwa H; Ohshio G; Imamura T; Watanabe G; Arii S; Imamura M; Narumiya S; Hiai H; Fukumoto M
Br J Cancer; 1998; 77(1):147-52. PubMed ID: 9459160
[TBL] [Abstract][Full Text] [Related]
19. A p27(kip1)-binding protein, p27RF-Rho, promotes cancer metastasis via activation of RhoA and RhoC.
Hoshino D; Koshikawa N; Seiki M
J Biol Chem; 2011 Jan; 286(4):3139-48. PubMed ID: 21087931
[TBL] [Abstract][Full Text] [Related]
20. DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms.
Healy KD; Hodgson L; Kim TY; Shutes A; Maddileti S; Juliano RL; Hahn KM; Harden TK; Bang YJ; Der CJ
Mol Carcinog; 2008 May; 47(5):326-37. PubMed ID: 17932950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
